Valley National Advisers Inc. Sells 4,610 Shares of HCA Healthcare, Inc. $HCA

Valley National Advisers Inc. trimmed its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 98.3% during the 3rd quarter, HoldingsChannel reports. The institutional investor owned 78 shares of the company’s stock after selling 4,610 shares during the period. Valley National Advisers Inc.’s holdings in HCA Healthcare were worth $33,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently made changes to their positions in HCA. BlackRock Inc. acquired a new position in HCA Healthcare during the 2nd quarter worth $5,069,974,000. Wellington Management Group LLP grew its position in shares of HCA Healthcare by 20.5% in the second quarter. Wellington Management Group LLP now owns 4,707,473 shares of the company’s stock valued at $1,835,397,000 after purchasing an additional 799,761 shares during the last quarter. Darsana Capital Partners LP increased its stake in shares of HCA Healthcare by 46.7% in the second quarter. Darsana Capital Partners LP now owns 1,100,000 shares of the company’s stock worth $428,879,000 after purchasing an additional 350,000 shares during the period. Legal & General Group Plc bought a new position in shares of HCA Healthcare in the second quarter worth about $410,992,000. Finally, Jupiter Topco LLC acquired a new position in shares of HCA Healthcare during the 2nd quarter worth about $371,138,000. Institutional investors and hedge funds own 62.73% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of brokerages have recently commented on HCA. Barclays cut their price target on HCA Healthcare from $402.00 to $387.00 and set an “equal weight” rating for the company in a report on Monday, July 27th. TD Cowen boosted their target price on shares of HCA Healthcare from $431.00 to $460.00 and gave the stock a “buy” rating in a research report on Monday, October 12th. Robert W. Baird cut their target price on shares of HCA Healthcare from $396.00 to $393.00 and set a “neutral” rating for the company in a research note on Monday, July 27th. Oppenheimer reduced their price target on shares of HCA Healthcare from $520.00 to $485.00 and set an “outperform” rating for the company in a report on Monday, July 27th. Finally, Raymond James Financial set a $528.00 price objective on shares of HCA Healthcare in a report on Tuesday, July 7th. Sixteen analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $467.50.

HCA Healthcare Trading Down 1.0%

Shares of HCA stock opened at $464.45 on Tuesday. HCA Healthcare, Inc. has a 12 month low of $353.99 and a 12 month high of $556.52. The company has a market capitalization of $100.55 billion, a P/E ratio of 15.55, a P/E/G ratio of 1.58 and a beta of 1.10. The stock has a 50 day moving average of $431.57 and a two-hundred day moving average of $445.15.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings data on Friday, July 24th. The company reported $7.59 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $7.56 by $0.03. The business had revenue of $20.23 billion for the quarter, compared to analysts’ expectations of $19.76 billion. HCA Healthcare had a negative return on equity of 244.79% and a net margin of 8.77%. HCA Healthcare’s quarterly revenue was up 8.7% on a year-over-year basis. During the same period in the previous year, the business posted $6.84 earnings per share. Sell-side analysts predict that HCA Healthcare, Inc. will post 29.51 earnings per share for the current fiscal year.

HCA Healthcare Company Profile

HCA Healthcare, Inc is a healthcare services company that operates hospitals, ambulatory surgery centers, emergency care facilities, physician practices and other healthcare sites. Its facilities provide a broad range of services, including acute and emergency care, surgery, cardiology, oncology, women’s and children’s services, behavioral health and outpatient care.

The company serves patients primarily across the United States through a network of healthcare facilities in numerous states.